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A national study of choanal atresia in
tertiary care centers in Canada – part II:
clinical management
Josee Paradis1,2*, Agnieszka Dzioba1, Hamdy El-Hakim3, Paul Hong4,5, Frederick K. Kozak6,7, Lily H. P. Nguyen8,9,10,
Demitri Perera11, Evan Jon Propst12, Jennifer M. Siu12, Monika Wojtera2, Murad Husein1,2 and National Choanal
Atresia Study Working Group

Abstract
Background: To evaluate the clinical management of choanal atresia (CA) in tertiary centers across Canada.
Methods: Multi-centre case series involving six tertiary care pediatric hospitals across Canada. Retrospective chart
review of patients born between 1980 and 2010 diagnosed with choanal atresia to a participating center.
Results: The health charts of 215 patients (59.6% female) with choanal atresia (CA) were reviewed. Mean age of
initial surgical repair was 0.8 months for bilateral CA, and 48.6 months for unilateral CA. Approaches of surgical
repair consisted of endoscopic transnasal (31.7%), non-endoscopic transnasal (42.6%), and transpalatal (25.2%).
Stents were used on 70.7% of patients. Forty-nine percent of patients were brought back to the OR for a planned
second look; stent removal being the most common reason (86.4%). Surgical success rate of initial surgeries was
54.1%. Surgical technique was not associated with rate of restenosis [χ2 (2) = 1.6, p = .46].
Conclusions: The present study is the first national multi-institutional study exploring the surgical outcomes of CA
over a 30-year period. The surgical repair of CA presents a challenge to otolaryngologists, as the rate of surgical
failure is high. The optimal surgical approach, age at surgical repair, use of stents, surgical adjuncts, and need for
planned second look warrant further investigation.
Keywords: Choanal atresia, Surgical repair, Post-operative management, Planned second look, Surgical adjuncts

Background
Choanal atresia (CA) is a congenital condition resulting
in obstruction of the posterior nasal passage(s), known
as the choana, with an incidence of approximately one
in 5000 to 8000 live births [1, 2]. Management of CA
* Correspondence: Josee.Paradis@lhsc.on.ca
This manuscript will be presented at the 2020 Canadian Society of
Otolaryngology virtual meeting in Canada (November 7-10, 2020) as an oral
presentation.
1
Department of Paediatric Otolaryngology- Head and Neck Surgery,
Children’s Hospital at London Health Sciences Centre, London, ON, Canada
2
Otolaryngology-Head and Neck Surgery, Schulich School of Medicine and
Dentistry, Western University, London, ON, Canada
Full list of author information is available at the end of the article

involves surgical resection of the atretic plate and surrounding structures [3]. The most common approaches
to surgical repair of CA include endoscopic transnasal
(ETN), non-endoscopic transnasal (NTN), and transpalatal (TP), with the ETN being the currently favored approach [4]. In addition, adjunct procedures are often
employed including laser-assisted surgery, placement of
nasal stents, and use of anti-proliferatives [4–8].
To date, best practices for management of CA remain
to be determined. Method of surgical correction of CA is
usually dictated by surgeon or institutional preference [9].
Postoperative, rates of restenosis remain unclear [7, 9].
Controversies regarding the use of stents in aiding surgical
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correction of CA [4, 5], minimizing restenosis as well as
the use of other adjunct procedures such as laser [6, 7]
and Mitomycin-C [8] remain unresolved. Furthermore,
the purpose and benefit of following up in the operating
room with a planned second look post initial surgical repair is under-reported in the literature.
The reasons for these unresolved controversies regarding best practices for clinical management of CA
is partly due to the rarity of the disorder and consequently the limited level of evidence available in the
literature. Published studies often report case series of
single surgeon or single institution experiences, involving small sample sizes [9–11], with few studies
reporting treatment outcomes on samples sizes larger
than 30 [11–16].
The aim of the current study is to elucidate controversies surrounding the management of CA using a
multi-institutional approach. The Canadian landscape
lends a unique setting to evaluate the management of
CA, as all CA repairs are performed in academic settings. In a two-part study, this national investigation
provides a comprehensive review of the clinical presentation (Part I) and management (Part II) of a large
sample of patients with CA treated at tertiary care
centres across Canada. The present paper reports on
the clinical management of CA. Specifically, the following outcomes were explored: surgical management
and use of adjunct procedures, utilization of a postoperative planned second look, and success rate of
surgical repair for CA.

Methods
Pediatric otolaryngologists practicing in tertiary care
centers across Canada were invited to take part in the
study via phone or email. Of the nine healthcare centers
who were contacted, six centers (Western University in
London, University of Toronto in Toronto, University of
Alberta in Edmonton, University of British Columbia in
Vancouver, McGill University in Montreal and Dalhousie University in Halifax) agreed to participate in the
chart review. Health records of patients born between
1980 and 2010 diagnosed with CA who underwent treatment at participating centers were included in this study.
Patients born before 1980 or after 2010 or patients who
did not receive a definitive diagnosis of CA were excluded from the study. A standardized checklist was
completed for each patient presenting with CA who met
study inclusion/exclusion criteria. The following variables were collected from patient chart review: surgical
approach, surveillance, surgical instruments, adjuncts to
surgery, findings of planned second look, revision surgeries, reasons for revision surgeries, and, a comparison
of surgical revision rates between surgical approaches,
and for bilateral versus unilateral cases of CA. In the
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current sample, surgical success was defined as presence
of choanal patency, with no need for surgery for restenosis or debridement of granulation tissue after initial repair. Each participating center obtained ethical approval
for this study from their institution’s Health Research
Ethics Board.
Data analysis

A descriptive analysis of study outcomes is presented. In
addition to descriptive statistics, results of chi-square
tests/Fisher’s exact tests, independent samples t-tests,
and Spearman rho correlation coefficients were reported
where appropriate. Statistical tests were conducted with
SPSS (IBM Corp. Released 2017. IBM SPSS Statistics for
Windows, Version 25.0. Armonk, NY: IBM Corp). Alpha
was set a priori at .05 to determine statistical
significance.

Results
Two-hundred and fifteen patients across the six participating centers [London (n = 26), Toronto (n = 83),
Edmonton (n = 17), Vancouver (n = 60), Montreal (n =
11), Halifax (n = 18)] met the study inclusion/exclusion criteria and were included in this national study.
Health records of 215 patients were reviewed. Onehundred and twenty-seven patients (59.6%) were
female and 88 (40.9%) were male. The mean age of
patients at time of CA presentation was 0.4 months
(range 0.1 to 7.2 months) for bilateral CA and 37.8
months (range 0.1 to 164.1 months) for unilateral
cases.
Surgical repair

Three common surgical techniques were utilized on patients for correction of CA in the Canadian tertiary care
centers: endoscopic transnasal (ETN) (31.7%), nonendoscopic transnasal (NTN) (42.6%) and transpalatal
(TP) (25.2%) techniques. The ETN technique was used
from 1992 to 2010; NTN was used from 1980 to 2010;
and, the TP technique was used from 1985 to 2010.
Table 1 displays information on the surgical correction
and surveillance of this patient cohort. The mean age at
initial surgical repair for CA was 28.5 months: 0.8
months for bilateral CA and 48.6 months for unilateral
CA. For patients who underwent ETN surgery, common
surgical instruments included the stammberger punch,
urethral sound dilators, suction punch and backbiting
forceps. Adjuncts to the ETN technique included two reports (3.1%) of Mitomycin-C use and two reports (3.1%)
of Holmium-YAG laser assistance. For patients who
underwent the NTN surgery, commonly reported surgical instruments used included the Skeeter drill, Stammberger punch, urethral sound dilation, suction punch
and backbiting forceps. Adjuncts to the NTN approach
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Table 1 Surgical Repair and Surveillance of Choanal Atresia
(n = 215)
Variable

Category

No. (%)

Age at repair (months)

mean (SD)

28.54 (43.0)

Type of surgery

Transnasal (endoscopic)

64 (31.7)

Nasal Stents

Stent duration (days)

Planned second look

Transnasal (non-endoscopic)

86 (42.6)

Transpalatal

51 (25.2)

Other

1 (0.5)

Yes

128 (70.7)

No

53 (29.3)

mean (SD)

39.6 (50.7)

range

2.1 to 270.0

Yes

81 (49.1)

No

84 (50.9)

were more frequently reported than the ETN and TP approaches and included 33 cases (34.4%) of laser use (30
carbon dioxide and 3 Holmium-YAG) and 8 cases
(9.3%) of Mitomycin-C use. Finally, for patients who
underwent the TP surgery, common surgical instruments included drills, suction punch, bone punch and
bone rongeurs. There was only one reported case (2.0%)
of Mitomycin-C use and no laser use with the TP surgical technique subgroup.
Stents were used in 70.7% of patients (n = 128) and almost exclusively involved the use of endotracheal tubes
that varied in size from 3 to 5.5 mm; the exception was
one placement of an 18 French latex urological catheter
and one use of the nasal trumpet as a stent. Stents were
placed for an average of 39 days. Forty-nine percent (n =
81) of patients were brought into the OR after their initial repair for a planned second look. Reasons for a
planned second look included stent removal or replacement (86.4%), debridement of tissue granulation (17.3%),
examination with nasendoscopy, laryngoscopy or bronchoscopy (8.6%), laser revision (1.2%), and clot formation
under the hard palate (1.2%). Patients who had nasal
stents inserted were statistically significantly more likely
to require a planned second look in the OR than patients who did not have nasal stents (64.0 vs 14.0%) [χ2
(1) = 34.8, p < .001].
Patients with bilateral CA were significantly more
likely to have stents placed compared to patients with
unilateral CA [(68.5% vs 53.7%), χ2(1) = 17.7, p < .001].
Patients with bilateral CA also had their stents inserted
for an average of 1 month longer than patients with unilateral CA [t (211) = − 4.41, p < .001].
Findings of the planned second look indicated a
patent choana (16.0%), granulation tissue (16.0%), restenosis (4.9%), and mucus crust plugging of nasopharynx (2.5%), with most case reviewed (60.5%) not
reporting findings of the planned second look.
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Revision surgeries

Table 2 displays information on revision rates and surgical techniques. One hundred and five patients (50.7%)
underwent a 1st revision surgery. The mean (SD) time
from initial surgical repair to 1st revision surgery was
18.2 (30.6) months. Reasons for revision surgery included restenosis (73.3%), debridement of granulation
tissue (11.4%), stent replacement, repositioning or removal (9.5%) and unknown (5.7%). As such, of the 207
patients with known information on revision surgery,
112 patients did not require a revision surgery or underwent a revision surgery solely for the purpose of stent
removal, repositioning, or replacement, resulting in a
surgical success rate of 54.1%. In contrast, 95 patients
required 1 or more revision surgeries for restenosis or
presence of granulation tissue, representing a surgical
failure rate of 45.9%. Adjuncts to the 1st revision surgery
included 32 cases (30.5%) of laser use (30 CO2 and 2
Holmium-YAG) and 4 cases (3.8%) of Mitomycin-C use.
Fifty-one patients (25.6%) underwent a 2nd revision
surgery. The mean (SD) time from initial surgical repair
to 2nd revision surgery was 40.6 (48.1) months. Reasons
for 2nd revision included: restenosis (80.4%), debridement of granulation tissue (3.9%), stent removal (9.8%),
and unknown (5.9%). Adjuncts to 2nd revision surgeries
included 22 cases (43.1%) of laser use (19 CO2 and 3
Holmium-YAG) and 3 cases (5.9%) of Mitomycin-C use.
Twenty-six patients (12.1%) underwent a 3rd revision
surgery. The mean (SD) time from initial surgical repair
to 3rd revision surgery was 43.4 (48.1) months. Reasons
for a 3rd revision included: Restenosis (69.2%), debridement of granulation tissue (11.5%) and stent removal
(19.2%). Adjuncts to the 3rd repair surgeries included 11
cases (42.3%) of laser use (10 CO2 and 1 HolmiumYAG) and 1 case (3.8%) of Mitomycin-C use. Table 3
displays rates of adjunct procedures for primary and revision surgeries.
The median number of revision surgeries was 1 with a
range of 0 to 8 revision surgeries for the study cohort.
Table 4 displays rates of restenosis by initial surgical approach. Similar restenosis rates were found for all three
surgical approaches (ETN, NTN, TP). Surgical technique
was not statistically significantly associated with rate of
restenosis [χ2 (2) = 1.6, p = .46].
Bilateral versus unilateral CA

Table 5 displays surgical revision rates, comparing bilateral versus unilateral CA. Patients with bilateral CA
were statistically significantly more likely to have
stents placed compared to patients with unilateral CA
[(68.5% vs 53.7%), χ2(1) = 17.7, p < .001]. Patients with
bilateral CA also had their stents inserted for an average of 1 month longer than patients with unilateral
CA [t (211) = − 4.4, p < .001].
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Table 2 Revision Surgeries
Variable

Category

1st Revision
No. (%)

2nd Revision
No. (%)

3rd Revision
No. (%)

Revision required?

Yes

105 (50.7)

51 (25.6)

26 (13.5)

No

102 (49.3)

148 (74.4)

166 (86.5)

mean (SD)

18.2 (30.6)

40.6 (48.0)

43.4 (48.1)

Post-op time at revision (months)
Type of Revision

ETN

30/105 (28.6)

14/51 (27.5)

9/26 (34.6)

NTN

59/105 (56.2)

29/51 (56.9)

14/26 (53.8)

TP

12/105 (11.4)

5/51 (9.8)

0/26 (0)

Unknown

4/105 (3.8)

3/51 (5.9)

3/26 (11.5)

Note. ETN Endoscopic transnasal, NTN Non-endoscopic transnasal, TP Transpalatal

Patients with bilateral CA were not significantly more
likely to require a 1st revision surgery than unilateral
CA [(58.9% versus 44.4%), χ2(1) = 2.8, p = .10]. However,
patients with bilateral CA were significantly more likely
to require a 2nd and 3rd revision surgery [χ2(1) = 8.4,
p = .004; χ2(1) = 16.5, p < .001, respectively] than patients
with unilateral CA. Individuals with unilateral CA had a
median of 1 revision surgery (range 0 to 3 revision surgeries), while individuals with bilateral CA had a median
of 2 revision surgeries (range 0 to 8 revision surgeries).

Discussion
Choanal atresia presents a surgical challenge to otolaryngologists as the atresia often involves multiple
structures including the nasal septum, atretic plate,
lateral wall and skull base [17], and has a high rate of
restenosis and need for revision surgery. The present
investigation explored the clinical management and
surgical outcomes of CA over a 30-year period (1980
to 2010). This is the first national multi-institutional
study reporting on a large sample size of 215 patients
with CA. This study will contribute to the body of
knowledge on CA, particularly relative to surgical correction of the condition.
Surgical repair

Surgical success rates for CA repair vary widely in
the literature and range from 0 to 85% [17–20]. The
large range in outcome is likely attributed to variability in surgical technique, study sample, sample
sizes, and definition of surgical success, which is not
Table 3 Rates of Adjunct Procedures for Primary and Revision
Surgeries for CA
Surgery

Laser
No. (%) Patients

Mitomycin-C
No. (%) Restenosis

Primary Surgery (n = 215)

35 (16.3%)

11 (5.1%)

1st Revision (n = 105)

32 (30.5%)

4 (3.8%)

2nd Revision (n = 51)

22 (43.1%)

3 (5.9%)

3rd Revision (n = 26)

11 (42.3%)

1 (3.8%)

operationally defined in most published works or
standardized across studies [21]. We observed a surgical success rate of 54.1% for the entire cohort with
the primary surgery. Eladl and Khafagy (2016)
reviewed 112 cases of bilateral CA using transnasal
endoscopic CA repair and reported a 42% restenosis
rate [17], suggesting a 58% success rate. The present
study also found no difference in rates of 1st revision surgeries between the unilateral and bilateral
cases of CA, but statistically significantly higher rates
of 2nd (p = .004) and 3rd (p < .001) revision surgeries
for bilateral CA. Similarly, Kinis et al. (2014) reported on the success rate of the ETN approach on
33 patients with CA and reported a 53.8% restenosis
rate for bilateral CA and 23.1% restenosis rate for
unilateral CA [19].
The present investigation found no statistically significant differences in rates of restenosis between the
three surgical repair approaches (ETN, NTN, TP).
To the authors’ knowledge, no other studies to date
have statistically compared differences in rates of restenosis across different surgical techniques. ETN
seems to be the favored approach for CA repair reported in the literature [22], although in our sample,
the NTN approach was used most often. However,
considerable advances in endoscopic visualization,
surgical techniques, stents, have occurred over the
30-year study period. Other authors have reported
that the ETN repair is safe and effective, resulting in
good outcomes with or without stenting [4]. Various
studies have reported surgical success rates for the
ETN approach that range from 67 to 88% [5, 10],
while a meta-analysis of 20 studies reported a mean
success rate of 85.3% for ETN approach [23]. The
TP approach is often indicated in cases of exceptionally thick bony atresia or nasal alar stenosis [12].
However, due to high changes of cross-bite and high
arch deformity, the TP repair is not recommended
for children younger than 6 years [21]. As such, the
optimal surgical approach for CA repair remains unclear and is likely dictated by the anatomical
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Table 4 Rate of Restenosis by Initial Surgical Repair Type
Surgical Technique

No. (%) Patients

Transnasal (endoscopic)

64 (31.8)

No. (%) Restenosis
23 (35.9)

Transnasal (non-endoscopic)

86 (42.8)

36 (41.9)

Transpalatal

51 (25.4)

18 (35.3)

involvement of the atresia, technological advances
and surgeon preference.
Adjunct procedures

The need and utilization of a planned second look in the
OR to evaluate surgical outcome following initial atresia
repair is under-reported in the literature. A planned second look was undertaken in 49.1% of the current study
cohort. Patients who had nasal stents inserted were statistically significantly more likely to require a planned
second look in the OR (64.0%) than patients who did
not have nasal stents (14.0%) (p < .001) in the current
study cohort. In Eladl & Khafagy’s review of 112 cases of
bilateral CA, they reported a higher rate of second-look
procedures than the present study, where 61% of cases
had undergone the procedure. However, consistent with
the present study, Eladl & Khafagy’s study also found
that the need for a second-look evaluation was largely
attributed to stenting in that 74.5% of patients with a
stent compared to 20.6% who did not have stent placement had undergone a second-look evaluation [17]. As
such, nasal stent repositioning, replacement or removal
was the primary motive for a planned second look. The
benefit of a planned second look for non-stent cases require further investigation. For example, Eladl & Khafagy
[17] suggest that post-operative dilation using dilators
under endoscopic examination after initial repair of bilateral CA helps prevent restenosis and need for planned
second look. Further investigation into the utilization
and benefit of a planned second look following CA repair and the use of imaging to assess for recurrence is
warranted.
To date, the value of adjuvant procedures such as
Mitomycin-C, laser assisted techniques, and stenting is
not proven [9, 12, 24]. Newman et al. (2013) found no
statistically significant difference in the rate of restenosis

Page 5 of 7

for patients treated with Mitomycin-C, stenting, or subsequent dilation in 39 cases of CA in those treated with
the ETN approach [12], while Bozkurt et al. (2010)
found that the rate of restenosis was lower in 6 patients
treated with Mitomycin compared with 14 CA patients
not treated with Mitomycin following ETN repair [25].
In the present investigation, laser assisted surgery occurred most often with the NTN approach, wherein
38.4% of surgeries (n = 33) were assisted with carbon dioxide or holmium-YAG lasers, while 3.1% of ETN and
0% of TP surgeries utilized lasers to correct CA.
Mitomycin-C was used infrequently as an adjunct to
surgical repair and again was used more often following
NTN approaches (9.3%), than ETN (3.1%) or TP (2.0%)
approaches. Mitomycin-C is no longer used as an adjunct to surgical repair due to its carcinogenic
properties.
Post-operative stenting has not been proven to increase chances of surgical success [5, 21], even though
authors still recommend placement of stents in high risk
cases such as in neonates and bilateral CA [24]. A recently published meta-analysis of 15 studies evaluating
bilateral CA repair found similar surgical success rates
for stented (65%) versus non-stented (64%) patients [5].
Stent duration varies across studies from a couple of
days to a few months [5]. In the present investigation,
for the 70.7% of patients who were stented, stents were
placed for an average of 1.3 months, with patients with
bilateral CA having stents inserted for a month longer,
on average, than unilateral cases.
Study limitations

Although this large multi-center study presents a significant addition to the CA literature, several study limitations should be noted. First, due to the retrospective
nature of this study, patients were not randomized to
intervention groups and this study found significant variability in the instrumentation used, and adjunct procedures used across treatment groups. As such, rates of
restenosis across the three surgical approaches (ETN,
NTN, TP) may be confounded by patient characteristics
[bilateral vs. unilateral CA, anomalies, nature of atresia
(bony, membranous, mixed), thickness of the atresia,

Table 5 Comparison of Bilateral versus Unilateral Choanal Atresia
Variable

Unilateral (n = 122)
No. (%)

Bilateral (n = 93)
No. (%)

p-value

Stents

65 (53.7)

63 (68.5)

<.001

Mean (SD) stent duration (days)

27 (36)

56.7 (63.0)

<.001

1st Revision Surgery

52 (44.4)

53 (58.9)

.10

2nd Revision Surgery

20 (17.9)

31 (35.6)

.004

3rd Revision Surgery

5 (4.7)

21 (24.7)

<.001

Note. p-values represent results of an independent samples t-test for stent duration variable and results of chi-square tests for the remaining variables
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etc.] and use of adjunct procedures. As this was a retrospective study, these patient and treatment factors could
not be accounted for. To date, only two small randomized controlled trials have been conducted on CA; one
evaluating Mitomycin-C use versus no-use in 20 children who were treated with the ETN approach [26] and
one comparing stenting versus no stenting in 20 children with bilateral CA also treated with the ETN approach [27], while RCTs comparing different surgical
techniques have not been conducted to date. Prospective
RCTs comparing treatment approaches, stenting vs. no
stenting, Mitomycin-C, laser assisted surgery, and type
of atresia would help further clarify these outstanding
controversies around the management of CA.
Furthermore, three tertiary care centres in Canada did
not participate in the present investigation, limiting the
generalizability of study findings. Finally, given the
multi-institutional nature of this study, results of the
study may be confounded by institutional factors including variability in surgeon expertise, institutional preferences for use of different surgical techniques, time of
repair and use of adjunct procedures. This variability
across sites may limit the interpretability of study
findings.

Conclusions
This retrospective multi-center investigation reported on
over 30-years experience of patients with CA across tertiary care centers in Canada. Surgical repair type,
whether it be ETN, NTN, or TP was not statistically significantly associated with rate of restenosis, while a weak
negative association between age and number of revision
surgeries was found. Stenting was used often in this patient cohort and stent removal, repositioning, and replacement were the primary reasons for a planned
second look in the OR following initial surgical repair.
Laser use facilitated NTN approaches most frequently,
with limited use in ETN and no use in TP approaches.
Mitomycin-C was used infrequently in the present patient cohort. Future investigations regarding hereditary
linkages, the need for a planned second look, stenting,
laser and Mitomycin-C use, and surgical repair approaches are warranted.
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